药品注册申请号:080292
申请类型:ANDA (仿制药申请)
申请人:MYLAN
申请人全名:MYLAN PHARMACEUTICALS INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 PREDNISONE PREDNISONE TABLET;ORAL 5MG No No AB 1972/05/22 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/06/05 SUPPL-64(补充) Approval Labeling STANDARD
2024/05/31 SUPPL-53(补充) Approval Labeling STANDARD
2024/05/31 SUPPL-52(补充) Approval Labeling STANDARD
2024/05/31 SUPPL-51(补充) Approval Labeling STANDARD
2002/12/09 SUPPL-41(补充) Approval Manufacturing (CMC)
2000/11/13 SUPPL-38(补充) Approval Manufacturing (CMC)
1998/10/01 SUPPL-40(补充) Approval Manufacturing (CMC)
1998/06/29 SUPPL-39(补充) Approval Manufacturing (CMC)
1997/08/26 SUPPL-37(补充) Approval Manufacturing (CMC)
1997/08/26 SUPPL-36(补充) Approval Manufacturing (CMC)
1996/04/02 SUPPL-35(补充) Approval Labeling
1996/04/02 SUPPL-34(补充) Approval Manufacturing (CMC)
1996/04/02 SUPPL-33(补充) Approval Manufacturing (CMC)
1996/04/02 SUPPL-32(补充) Approval Manufacturing (CMC)
1996/04/02 SUPPL-31(补充) Approval Manufacturing (CMC)
1994/11/14 SUPPL-30(补充) Approval Labeling
1994/06/15 SUPPL-29(补充) Approval Manufacturing (CMC)
1994/06/15 SUPPL-27(补充) Approval Manufacturing (CMC)
1994/04/14 SUPPL-26(补充) Approval Manufacturing (CMC)
1994/02/09 SUPPL-28(补充) Approval Labeling
1993/07/23 SUPPL-25(补充) Approval Manufacturing (CMC)
1993/07/23 SUPPL-21(补充) Approval Manufacturing (CMC)
1993/07/23 SUPPL-20(补充) Approval Manufacturing (CMC)
1993/07/23 SUPPL-19(补充) Approval Labeling
1991/02/05 SUPPL-24(补充) Approval Manufacturing (CMC)
1988/12/06 SUPPL-18(补充) Approval Labeling
1988/10/07 SUPPL-17(补充) Approval Labeling
1986/10/14 SUPPL-16(补充) Approval Manufacturing (CMC)
1986/10/14 SUPPL-15(补充) Approval Manufacturing (CMC)
1984/11/13 SUPPL-14(补充) Approval Manufacturing (CMC)
1982/07/21 SUPPL-13(补充) Approval Manufacturing (CMC)
1972/05/22 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:PREDNISONE 剂型/给药途径:TABLET;ORAL 规格:5MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
080292 001 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription No No AB Approved Prior to Jan 1, 1982 MYLAN
080352 001 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription Yes Yes AB Approved Prior to Jan 1, 1982 HIKMA
080356 001 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription No No AB Approved Prior to Jan 1, 1982 WATSON LABS
089247 002 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription No No AB 1985/12/04 SUN PHARM INDUSTRIES
040362 002 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription No No AB 2001/08/29 JUBILANT CADISTA
040256 001 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription No No AB 2002/07/12 ENDO OPERATIONS
210525 005 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Discontinued No No AB 2018/12/07 GENEYORK PHARMS
211575 002 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription No No AB 2019/11/15 NOVITIUM PHARMA
213385 002 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription No No AB 2020/06/16 AMNEAL
208412 005 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription No No AB 2020/11/20 STRIDES PHARMA
215672 002 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Prescription No No AB 2022/03/28 AUROBINDO PHARMA LTD
212629 001 ANDA PREDNISONE PREDNISONE TABLET;ORAL 5MG Discontinued No No AB 2023/12/05 ALLIED
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database